View Sample PDF

Veterinary antibacterials--antiseptics that only act against bacteria--comprise some of the most important pharmaceutical products on the animal health market. Yet despite a difficult regulatory environment--driven by concerns over the development of antibacterial resistance in consumers of livestock products--new products are still being launched. This has resulted in significant changes in the animal health products market. This study offers a detailed examination of the shape of the animal health products market globally over the next several years specific to antibacterials, analyzing both the livestock and companion animal markets.

1. 1 Report Overview 4
2. 1.1 Objectives of Report 4
3. 1.2 Scope of Report 4
4. 1.3 Methodology 4
5. 1.4 Executive Summary 5
7. 2 Animal Health Products Antibacterial Markets 6
8. 2.1 Overview of Animal Health Products Market 6
9. 2.1.1 World Products Market 7
10. 2.1.2 U.S. Animal Health Products Market 8
11. 2.1.3 European Animal Health Products Markets 9
12. 2.1.4 Asian Animal Health Products Markets 10
13. 2.2 Key Sector Highlights 11
14. 2.3 Biologics Products Category 12
15. 2.4 Companion Animal Health Products 12
17. 3 Common Animal Diseases 13
18. 3.1 Swine Fevers (African, Classical - Hog Cholera) 16
19. 3.2 Yellow Fever 16
20. 3.3 Anthrax 16
21. 3.4 Crimean-Congo Hemorrhagic Fever 16
22. 3.5 Foot and Mouth Disease (FMD) 17
23. 3.6 Bovine Anaplasmosis 17
24. 3.7 Bovine Babesiosis 18
25. 3.8 Bovine Brucellosis 19
26. 3.9 Bovine Genital Campylobacteriosis 19
27. 3.10 Bovine Tuberculosis 19
28. 3.11 Bovine Cysticercosis 19
29. 3.12 Bovine Spongiform Encephalopathy 20
30. 3.13 Dermatophilosis 21
31. 3.14 Enzootic Bovine Leukosis 21
32. 3.15 Hemorrhagic Septicemia 21
33. 3.16 Infectious Bovine Rhinotracheitis / Infectious Pustular Vulvovaginitis 21
34. 3.17 Theileriosis 22
35. 3.18 Trichomonosis 22
36. 3.19 Vesicular Stomatitis 22
37. 3.20 Swine Vesicular Disease  Picornaviridae Enterovirus 23
38. 3.21 Rinderpest 23
39. 3.22 Peste Des Petits Ruminants 23
40. 3.23 Contagious Bovine Pleuropneumonia 23
41. 3.24 Lumpy Skin Disease 24
42. 3.25 Rift Valley Fever 24
43. 3.26 Bluetongue  Reoviridae Orbivirus 24
44. 3.27 Ovine Epididymitis (Brucella Ovis) 25
45. 3.28 Caprine and Ovine Brucellosis (Excluding B. Ovis) 25
46. 3.29 Caprine Arthritis/Encephalitis 25
47. 3.30 Contagious Agalactia 25
48. 3.31 Contagious Caprine Pleuropneumonia 26
49. 3.32 Enzootic Abortion of Ewes (Ovine Chlamydiosis) 26
50. 3.33 Avian Chlamydiosis 26
51. 3.34 Pullorum Disease 27
52. 3.35 Myxomatosis 27
53. 3.36 Tularemia 27
54. 3.37 Contagious Equine Metritis 28
55. 3.38 Dourine 28
56. 3.39 Epizootic Lymphangitis 28
57. 3.40 Porcine Brucellosis 28
58. 3.41 Commercially-Significant Bacterial Infections in Farm Animals 29
60. 4 Anti-bacterials Markets 31
61. 4.1 Overview 31
62. 4.2 Antibiotics Market Size 32
63. 4.3 Global Sales of Animal Health Antibiotics by Region 32
64. 4.3.1 U.S. Sales of Animal Health Antibiotics 32
65. 4.3.2 European Sales of Animal Health Antibiotics 36
66. 4.3.3 Japanese Sales of Animal Health Antibiotics 37
67. 4.4 Animal Health Antibiotics Market Drivers 37
68. 4.5 Growth Promotion in Livestock 38
70. 5 Regulatory Overview of the Veterinary Health Market 42
71. 5.1 Regulatory Environment 42
72. 5.2 General Overview 42
73. 5.3 Product Marketing Authority 43
74. 5.4 Regulation of Animal Health Products in the European Union 43
75. 5.5 Regulation of Animal Health Products in the U.S. 45
76. 5.5.1 USDA 45
77. 5.5.2 FDA 45
78. 5.5.3 EPA 46
79. 5.6 Regulation of Animal Health Products in Japan 46
80. 5.6.1 Japanese Regulatory Environment 46
81. 5.6.2 Withdrawal Periods 46
82. 5.6.3 Japanese Filing Procedures for New Animal Drug Applications 46
83. 5.6.4 Use of Outdated Animal Studies 46
84. 5.6.5 Brand-Specific Listing for Antimicrobial, Antibiotic and Other Feed Additives 47
85. 5.7 Proposed Regulation of Animal Antibiotics 47
86. 5.8 Antibiotic Acquired Resistance and Animal Usage 47
88. 6 Business Trends in the Industry 49
89. 6.1 European Animal Health Industry 49
90. 6.2 Trends Driving Demand 49
91. 6.3 Antibiotic Usage 49
92. 6.4 Mergers and Acquisitions 49
93. 6.5 Bioterrorism and Food-borne PathogensWHO Guidelines 50
94. 6.6 Animal Health Additive Growth Trends 50
96. 7 Company Profiles 52
97. 7.1 Abbott Laboratories 52
98. 7.2 Agricultural Research Service 52
99. 7.3 Alpharma, Inc. 53
100. 7.4 BASF Agricultural Products and Nutrition 55
101. 7.5 Bayer Animal Health 56
102. 7.6 Boehringer Ingelheim Corp. 56
103. 7.7 Elanco Animal Health 57
104. 7.8 Fort Dodge Animal Health (Wyeth) 57
105. 7.9 Heska Animal Health 58
106. 7.10 Intervet International 60
107. 7.11 IVAX Corporation 60
108. 7.12 Merial Animal Health 60
109. 7.13 Novartis Animal Health 61
110. 7.14 Pfizer Animal Health 62
111. 7.15 Roche Animal Nutrition and Health 65
112. 7.16 Sanofi-Aventis 66
113. 7.17 Schering-Plough Animal Health 67
114. 7.18 Virbac S.A. 68
115. 7.19 Wyeth (Fort Dodge Animal Health) 68
118. INDEX OF FIGURES
120. Figure 2.1: Worldwide Animal Health Products Market by Region, 2006 8
121. Figure 2.2: U.S. Companion Animal Healthcare Products Share of Overall Animal Health Product Sales, 2006 9
122. Figure 2.3: Worldwide Animal Health Products Market by Species, 2006 11
125. INDEX OF TABLES
127. Table 2.1: World Market for Animal Health Products, 2004-2012 7
128. Table 2.2: Global Sales of Animal Health and Nutrition Products, 2004-2012 7
129. Table 2.3: Worldwide Animal Health Products Market by Region, 2006 8
130. Table 2.4: U.S. Animal Health Product Sales, 2004-2012 9
131. Table 2.5: Japanese Animal Health Market, 2000-2012 10
132. Table 2.6: Worldwide Animal Health Product Sales for Leading Producers, 2006 10
133. Table 2.7: Dog and Cat Food Manufacturers 12
134. Table 3.1: Diseases 13
135. Table 3.2: Multiple Species Diseases 13
136. Table 3.3: Cattle Diseases 14
137. Table 3.4: Sheep and Goat Diseases 14
138. Table 3.5: Equine Diseases 14
139. Table 3.6: Swine Diseases 15
140. Table 3.7: Avian Diseases 15
141. Table 3.8: Fish Diseases 15
142. Table 3.9: Other Veterinary Diseases 16
143. Table 3.10: Use Categories for Anti-bacterials in Animal Health 29
144. Table 3.11: Commercially-Significant Bacterial Infections in Pigs 29
145. Table 3.12: Commercially-Significant Bacterial Infections in Poultry 30
146. Table 3.13: Commercially-Significant Bacterial Infections in Cattle 30
147. Table 4.1: Leading Antimicrobials by Type for Animal Health 31
148. Table 4.2: Antibiotics Used in Animal Health by Family 32
149. Table 4.3: Worldwide Sales of Animal Health Antibiotics, 2004-2012 32
150. Table 4.4: U.S. Sales of Animal Health Antibiotics, 2004-2012 33
151. Table 4.5: U.S. Volume of Animal Health Antibiotics Used, 1999-2006 33
152. Table 4.6: Sales of Bayer's Baytril®, 2003-2009 34
153. Table 4.7: Enrofloxacin (Quinolones) 34
154. Table 4.8: Antibiotic Susceptibility for Common Swine Pathogens vs. Excenel® 35
155. Table 4.9: U.S. Volume of Animal Health Antibiotics Used by Class Category, 2000-2005 35
156. Table 4.10: European Sales of Animal Health Antibiotics, 2004-2012 36
157. Table 4.11: European Veterinary Consumption of Therapeutic Antibiotics 36
158. Table 4.12: Japanese Sales of Animal Health Antibiotics, 2004-2012 37
159. Table 4.13: Animal Health Antibiotics Market Drivers 37
160. Table 4.14: Commercial Animal Health Anti-bacterials by Class Type 40
161. Table 4.15: Bacterial and Protozoal Threats to Poultry 41
162. Table 4.16: Bacterial and Protozoal Threats to Pigs 41
163. Table 7.1: Pfizer Animal Health Products 63
164. Table 7.2: Pfizer Livestock Products 65
165. Table 7.3: Pfizer Equine Products 65
166. Table 7.4: Pfizer Companion Animal Products 65